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The novel Ca2-binding protein, Scarf (skin calmodulin-re-
lated factor) belongs to the calmodulin-like protein family and is
expressed in the differentiated layers of the epidermis. To deter-
mine the roles of Scarf during stratification, we set out to iden-
tify the binding target proteins by affinity chromatography and
subsequent analysis by mass spectrometry. Several binding fac-
tors, including 14-3-3s, annexins, calreticulin, ERp72 (endo-
plasmic reticulum protein 72), and nucleolin, were identified,
and their interactions with Scarf were corroborated by co-im-
munoprecipitation and co-localization analyses. To further
understand the functions of Scarf in epidermis in vivo, we
altered the epidermal Ca2 gradient by acute barrier disruption.
The change in the expression levels of Scarf and its binding tar-
get proteins were determined by immunohistochemistry and
Western blot analysis. The expression of Scarf, annexins, calre-
ticulin, and ERp72 were up-regulated by Ca2 gradient disrup-
tion, whereas the expression of 14-3-3s and nucleolin was
reduced. Because annexins, calreticulin, and ERp72 have been
implicated in Ca2-induced cellular trafficking, including the
secretion of lamellar bodies and Ca2 homeostasis, we propose
that the interaction of Scarf with these proteins might be cru-
cial in the process of barrier restoration. On the other hand,
down-regulation of 14-3-3s and nucleolin is potentially
involved in the process of keratinocyte differentiation and
growth inhibition. The calcium-dependent localization and
up-regulation of Scarf and its binding target proteins were
studied in mouse keratinocytes treated with ionomycin and
during the wound-healing process. We found increased
expression and nuclear presence of Scarf in the epidermis of
the wound edge 4 and 7 days post-wounding, entailing the
role of Scarf in barrier restoration. Our results suggest that
Scarf plays a critical role as a Ca2 sensor, potentially regu-
lating the function of its binding target proteins in a Ca2-de-
pendent manner in the process of restoration of epidermal
Ca2 gradient as well as during epidermal barrier formation.
Calcium (Ca2) is a ubiquitous intracellular messenger that
influences numerous cellular processes, such as proliferation,
development, and muscle contraction among others. Epider-
mal differentiation is one of the Ca2-dependent processes.
Mouse keratinocytes cultured in low Ca2 medium (0.05 mM)
proliferate repeatedly, but do not differentiate unless the Ca2
concentration exceeds 0.1 mM (1–3). Upon the change into the
higher Ca2 concentration, the cultured keratinocytes stop
proliferating and begin to differentiate. In vivo, an endogenous
Ca2 gradient is present in the epidermis of neonatal and adult
hairless mice (4). It has been proposed that changes in intracel-
lular Ca2 concentration, which result from both the intercel-
lular Ca2 accumulation in the mid granular layers and Ca2
influx from the upper granular layers, regulate epidermal dif-
ferentiation. Acute disruption of epidermal permeability by
either repeated tape stripping or acetone treatment can alter
this Ca2 gradient in the skin (5). The responses following skin
barrier disruption involve: a loss of Ca2 from the outer epider-
mis (stratum granulosum) (6), rapid secretion of lamellar bod-
ies from the outermost granular layers (7) and increased lipid
and DNA synthesis (8–11). The Ca2 concentration in the
outer layers of the epidermis decreases 3 h after disruption and
is restored after 6–24 h (12).
Mechanisms that lead to an increase in intracellular Ca2
concentration include the release of Ca2 from intracellular
storages, such as endoplasmic reticulum (ER)2 or sarcoplasmic
reticulum in muscle, as well as Ca2 influx across the plasma
membrane using voltage- or receptor-operated channels (13,
14). Themajority of released or imported Ca2 in the cytosol is
bound to buffer molecules, including Ca2-binding proteins
(13). An essential role for the transduction of the Ca2 signal is
undertaken by the Ca2-binding proteins, which are character-
ized by the presence of a helix-loop-helix Ca2-binding motif
termed EF-hand. The conformational changes of the EF-hand
upon binding of Ca2 can allow these proteins to interact with
a range of specific binding targets and in this way regulate their
function (15, 16). Ca2-binding proteins, such as human calm-
odulin-like protein (17), human calmodulin-like skin protein
(Clsp) (18), and S100 proteins (19–21), have been characterized
in the epidermis with ongoing efforts on studying their func-
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tion. In previous studies, we have reported the characterization
of the novel mouse skin-specific Ca2-binding proteins, Scarf
(skin calmodulin-related factor), and Scarf2 (22) with their
expression patterns being very similar and highly expressed in
the differentiated layers of the murine epidermis (22, 23).
Here, we have examined the roles of Scarf during the epidermal
differentiationprocess. Sevenbinding targetproteinsofScarfwere
identified, and their interactions with Scarf were analyzed during
epidermal barrier disruption andwoundhealing.Wepropose that
Scarfplaysacritical roleasaCa2 sensor regulating the functionof
its binding target proteins in a Ca2-dependent manner during
epidermal stratification and barrier recovery.
EXPERIMENTAL PROCEDURES
Scarf and Anti-Scarf Antibody Affinity Chromatography—
Recombinant Scarf (rScarf) protein and purified anti-Scarf
antibody were immobilized separately onN-hydroxysuccinim-
ide-activated Sepharose columns according to themanufactur-
er’s instructions (Amersham Biosciences). The coupling effi-
ciency was 95%, calculated from the ratio of rScarf or anti-Scarf
antibody in solution before and after incubationwith thematrix
of the column. Neonatal mouse epidermis was homogenized in
a lysis buffer (10 mM Hepes, pH 7.9, 150 mM NaCl, 0.1% Triton
X-100, and protease inhibitors) and then centrifuged at
10,000 g for 10 min at 4 °C. After passing through a 0.22-m
filter, the Ca2 concentration of the supernatants was adjusted
to 2.5 mM before applying onto the columns. Elution was per-
formed using 0.1 N glycine, and the eluted proteins were then
subjected to SDS-PAGE for mass spectrometry analysis.
Mass Spectrometry—Proteins were visualized using a colloi-
dal Coomassie Blue staining kit (Invitrogen) (24). Visible bands
were excised, and proteins were digested with porcine trypsin
(Promega) using a MassPREP station (Waters Associates) by a
process that included extensive destaining and reduction/alky-
lation with iodoacetamide. After extraction from the gel pieces,
the liquid samples were in vacuo concentrated to12 l.
Liquid chromatography-coupled tandemmass spectrometry
analysis was performed using aWaters CapLC system. 6.4l of
the sample was injected onto a C-18 reverse phase trap column
(Optipak Symmetry 300, Waters Associates). After 5 min, the
flowwas reversed through the trap column,which then coupled
to a microbore high performance liquid chromatography col-
umn (VC-10-C18w-150, 5 m, 0.15 mm 10 cm, Micro-Tech
Scientific). Solution A contained 0.2% formic acid and 1% ace-
tonitrile, and solution B was composed of 0.2% formic acid, 1%
water, and 98.8% acetonitrile. The gradientwas 5%of solutionB
for 5 min to 35% of solution B by 15 min to 90% of solution B in
25min.The electrospraywas generated by the nebulizing nano-
flow accessory, which is available with the interface at a capil-
lary voltage of 3.5 kV. Trapping flow rates were 10 l/min, and
analytical flow rates were1 l/min. Data-dependent analysis
was performed with up to three parent ions of charges 2, 3, 4 in
any given departure from direct mass spectrometry measure-
ments, with time and ion count based on control of the length of
tandemmass spectrometry data collection. The dynamic exclu-
sion for 30–45 s was included to reduce ion remeasurement.
Datawere then processed to *.pkl files using the vendor package
Masslynx (Waters Associates) with no cut off for tandem mass
spectrometry data. Searches were then performed using the
Mascot search engine (Center for Information Technology,
National Institutes of Health).
Co-immunoprecipitation and Western Blot Analysis—Pri-
mary mouse keratinocytes were isolated from trypsinized new-
born BALB/c mouse skins and lysed by repeatedly freezing and
thawing in lysis buffer (10 mM Hepes, pH 7.9, 150 mM NaCl,
0.1% Triton X-100, and protease inhibitors). The lysates were
centrifuged at 10,000 g for 10 min at 4 °C, and supernatants
were used as the cell extracts after the Ca2 concentration was
adjusted to 2.5 mM.
The ProFound co-immunoprecipitation kit (Pierce) was
used according to themanufacturer’s instructions. Briefly, each
antibody (chicken anti-Scarf, mouse anti-14-3-3 (Upstate
Biotechnology), rabbit anti-14-3-3 (Upstate Biotechnology),
mouse anti-annexin II (BD Biosciences), rabbit anti-annexin V
(Abcam, Inc.), rabbit anti-calreticulin (Upstate Biotechnology),
rabbit anti-ERp72 (Stressgen), mouse anti-nucleolin (Abcam,
Inc.)) and both IgG and IgY as controls were immobilized onto
biosupport medium by amine-coupling chemical reaction. Cell
extracts were then incubated with each immobilized antibody
for 2 h at 4 °C in the presence or absence of 10 mM EDTA. The
beads were washed extensively with lysis buffer in the same
conditions. Protein sampleswere eluted and subjected toWest-
ern blot analysis. Phosphate-buffered saline containing both
10% BLOKHen IITM (Aves Laboratories, Inc.) and 5% goat
serumwas used as the blocking solution to prevent nonspecific
binding. The immunoreactive proteins were detected accord-
ing to the enhanced chemiluminescence protocol (Pierce)
using the horseradish peroxidase-linked secondary antibody
(Vector Laboratories).
Epidermal Ca2 Gradient Disruption—The epidermal Ca2
gradient was disrupted in 8–12-week-old hairless mouse skin
(from the animal laboratory of Yonsei University) while the
animals were under general anesthesia with 4% chloral hydrate
administered intraperitoneally and repeatedly tape-stripped on
one flank with cellophane tape. The procedure was performed
until the transepidermal water loss reached 40 g/m2/h.
Untreated sites on the same animals served as controls. Meth-
ods for acute barrier disruption and transepidermal water loss
measurements have been reported (7, 25).
Immunofluorescence and Confocal Microscopy—Immun-
ofluorescent staining was performed on paraffin sections of
adult hairless mouse skin. The deparaffinized sections were
treated with a 1:500 dilution (except for rabbit anti-filaggrin
antibody, which was used at 1:2000) of the antibodies used in
the co-immunoprecipitation analysis overnight at 4 °C. After
washing, the sections were incubated with 1:500 dilutions of
secondary antibodies for 1 h at room temperature, which
included an anti-chicken fluorescein isothiocyanate (FITC)-
conjugated antibody (Cappel) and an anti-rabbit ormouse rho-
damine-conjugated antibody (Jackson ImmunoResearch Labo-
ratories). The slides were mounted with Vector Shield (Vector
Laboratories) and examined using laser scanning confocal
microscope 510 Meta (Zeiss).
Cell Culture, Transient Transfections, and Ionomycin
Treatment—Transformed PAM212 primary mouse keratino-
cytes were grown in Eagle’s minimal essential medium supple-
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mented with 10% chelex-treated fetal bovine serum (2, 22).
Ca2 concentration was determined by analysis in an atomic
absorption spectrophotometer. Unless otherwise indicated, the
Ca2 concentration of the medium was adjusted to 0.05 mM to
maintain a basal cell-like population of undifferentiated cells.
The open reading frame for Scarf and V5-tagged annexin V
(tag at the 3 end) were cloned into pCMV-Script (Stratagene).
Keratinocytes were co-transfected using FuGENE 6 transfec-
tion reagent (Roche Applied Science) and incubated for 24 h to
allow gene expression. Cells were treated with 2.5 M ionomy-
cin (Calbiochem) for 30 min before 4% paraformaldehyde fixa-
tion and then permeabilized with 0.2% Triton X-100 in phos-
phate-buffered saline. Immunofluorescence was performed
with anti-Scarf and anti-V5 antibodies as described above.
Human Skin Specimens, Wounding, and Histology—Speci-
mens of normal human skin were obtained as discarded tissue
following reduction mammoplasty (approved protocol
H#25121) and maintained as described previously (26).
Wounds were created using 3-mm punch biopsies through the
reticular dermis, and the specimens were maintained on an
air-liquid interface for 4 and 7 days as previously reported (27).
Each time point was collected in parallel with an unwounded
skin specimen from the same donor. Samples were fixed in 10%
formalin and paraffin-embedded. 7-mm skin sections were cut
and stained with anti-chicken Scarf antibody (1:200) diluted in
phosphate-buffered saline with 0.1% Triton X-100 (Sigma) and
visualized using an anti-chicken FITC-conjugated antibody
(1:250; Cappel). All sections were stained withHoechst (Sigma)
for visualization of the nucleus. All negative controls were pre-
pared by omitting the primary antibody. The sectionswere ana-
lyzed using a Carl Zeiss microscope, and digital images were
collected using the Adobe TWAIN_32 program.
RESULTS
Identification of Scarf-binding Target Proteins—To deter-
mine the roles of Scarf during the epidermal differentiation
process, we set out to identify its binding target proteins.
Recombinant Scarf (rScarf) protein and affinity-purified anti-
Scarf antibody were immobilized separately on N-hydroxysuc-
cinimide-activated Sepharose beads and used to capture target
proteins from neonatal mouse epidermis. The eluted proteins
were subjected to electrophoresis on a polyacrylamide gel,
which was then stained with colloidal Coomassie Blue (Fig. 1).
The identity of the bands in each preparation was determined
by mass spectrometry after a trypsinization process. Binding
target proteins identified in rScarf (Fig. 1, rS, left panel) or anti-
Scarf antibody (S-Ab, right panel) columns were 14-3-3, 14-3-
3, annexin II, annexin V, calreticulin, endoplasmic reticulum
protein 72 (ERp72), and nucleolin. The match score and
sequence coverage (%), which indicate sequence identity
between binding target proteins and trypsinized peptides from
the bands of the polyacrylamide gel, are shown in Table 1.
Annexin II, calreticulin, and ERp72 were marked with high
match score and sequence coverage (%) in both rScarf and anti-
Scarf antibody columns.
Ca2 Affects Scarf-binding Target Protein Interactions—The
expression of the seven Scarf-binding target proteins was cor-
roborated in primary mouse keratinocytes by Western blot
analysis (Fig. 2A). Cell extractswere prepared from total (T) and
suprabasal (S) keratinocytes isolated by Percoll gradient from
neonatal mouse skins (22). Western blot analysis with antibod-
FIGURE 1. Identification of binding target proteins interactingwith Scarf
by affinity chromatography andmass spectrometry. Affinity chromatog-
raphy was performed using extracts from neonatal mouse epidermis. Two
affinity columns were prepared, one with recombinant Scarf protein (rS, left
panel) and the other with anti-Scarf antibody (S-Ab, right panel), and eluted
proteins were subjected to electrophoresis on a polyacrylamide gel. Excised
bands from gel were then analyzed by mass spectrometry. Several binding
target proteins, including 14-3-3 and , annexins II and V, calreticulin,
ERp72, and nucleolin were identified.
TABLE 1
Determination of Scarf binding target proteins interacting by mass spectrometry
Data related to binding target proteins were obtained from theMascot search engine by CIT,National Institutes of Health. rS, recombinant Scarf; S-Ab, anti-Scarf antibody;
ANX II, annexin II; ANX V, annexin V; CRT, calreticulin; ERp72, Endoplasmic reticulum protein 72; NUC, nucleolin; ND, not determined.
Sample
identification Protein
Swiss-Prot
accession no.
rS-affinity S-Ab affinity
Match score Sequence coverage Match score Sequence coverage
% %
1 14-3-3 Q9JJ20 66 11 131 14
2 14-3-3 143B MOUSE 57 7 118 10
3 ANX II ANX2_MOUSE 306 35 275 19
4 ANX V AQHUP 40 3 ND ND
5 CRT S06763 394 35 467 38
6 ERp72 ISMSER 210 13 242 15
7 NUC BAC38858 ND ND 57 4
Scarf and CalciumHomeostasis
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ies specific for each binding target protein determined that all
of these proteins are expressed in the differentiated layers of
mouse epidermis. To verify their interaction with Scarf, co-
immunoprecipitation analysis was performed with antibodies
specific for 14-3-3, 14-3-3, annexin II, annexin V, calreticu-
lin, ERp72 and nucleolin, and cell extracts from primary mouse
keratinocytes. Western blot with anti-Scarf antibody con-
firmed their interaction with Scarf (Fig. 2B). Anti-IgG and anti-
IgY antibodies were used as negative controls.
The effect of Ca2 on Scarf-binding target protein interac-
tions was also examined by co-immunoprecipitation analysis
(Fig. 3). Annexin II, annexin V, calreticulin, and ERp72 were
co-immunoprecipitated with anti-Scarf antibody and visual-
ized byWestern blot using previously specified antibodies (Fig.
3A), whereas the interactions of 14-3-3, 14-3-3 and nucleo-
lin were verified with Western blots using anti-Scarf antibody
after co-immunoprecipitation with each antibody (Fig. 3B). All
of these interactions were Ca2-dependent, because the addi-
tion of EDTA abolished or strongly diminished the binding
(Fig. 3). The interaction of Scarf with 14-3-3s and nucleolin
could only be detected when co-immunoprecipitated with spe-
cific antibodies raising the possibility that these proteins might
not bind directly to Scarf but form a complex with intermediate
molecules that interact Scarf.
Localization of Binding Target Proteins and Scarf Expression—
Detection of Scarf and binding target proteins was visualized in
adult mouse skin sections by immunofluorescent staining and
confocal microscopy (Fig. 4). Scarf was stained with FITC-con-
jugated secondary antibody (first panel), the binding target pro-
teins were detected with a rhodamine-conjugated secondary
FIGURE 2. Expression and interaction between Scarf and its binding tar-
get proteins was confirmed by Western blot and co-immunoprecipita-
tion analysis. A, equal amounts of total protein from extracts of total (T) and
suprabasal (S) keratinocytes were loaded onto SDS gel, and Western blot
analysis was performed with antibodies specific for each binding target pro-
tein. All binding target proteins were expressed in primary mouse keratino-
cytes and in the suprabasal layer of mouse epidermis. B, co-immunoprecipi-
tation analyseswere performedwith anti-14-3-3, anti-14-3-3, anti-annexin
II, anti-annexin V, anti-calreticulin, anti-ERp72, and anti-nucleolin antibodies
using cell extracts from primary mouse keratinocytes. Their interactions with
Scarf were then confirmed by subsequent Western blot analysis with anti-
Scarf antibody. Anti-IgG and anti-IgY antibodies were used as controls.
FIGURE 3. Ca2 effects on the interactions between Scarf and its binding
targetproteins. Theeffects of Ca2on the interactionsbetweenScarf and its
binding target proteins were examined by co-immunoprecipitation analysis
in the presence and absence of EDTA. A, co-immunoprecipitation with anti-
Scarf antibody detected the interactions of Scarf with annexin II, annexin V,
calreticulin, and ERp72 in the absence () and presence () of EDTA. B, Ca2
effects on interactions with 14-3-3s and nucleolin were also visualized by
co-immunoprecipitation in the absence () and presence () of EDTA. The
lower panels for eachprotein demonstrates that EDTAdoes not have an effect
on either the protein-antibody recognition itself or antibody immobilization
to the co-immunoprecipitation columns.
Scarf Merge
ANX V
CRT
ERp72
NUC
14-3-3 σ
14-3-3β
ANX II
FIGURE4.Localizationof Scarf andbinding targetproteins inmouseneo-
natal epidermis. Scarf was detected using an anti-Scarf chicken antibody
and a secondary FITC-conjugated antibody (green, left panels), and binding
target proteins (14-3-3, 14-3-3, annexin II, annexin V, calreticulin, ERp72
and nucleolin) were visualized using specific antibodies followed by rhoda-
mine-conjugated secondary antibody (red, middle). Merged images are
shown in the third panels. Right panels are the magnifications of the circled
areas in the merged panels. All binding target proteins are expressed with
Scarf in thedifferentiated layers ofmouseepidermis. Adotted linedemarcates
the epidermis/dermis junction. Scale bar, 30 m.
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antibody (second panel), and themerged andmagnified images
appear on the third and fourth panels, respectively. The expres-
sion pattern of Scarf is consistent with previous reports (22, 23)
showing that Scarf is expressed in the differentiated layers of
the mouse epidermis. 14-3-3, 14-3-3, and annexin V were
expressed primarily in granular layers of adult mouse epider-
mis, whereas calreticulin, ERp72, and nucleolin were expressed
throughout the adultmouse epidermis. Themerged images and
panel withmagnified images (Fig. 4, right panel) show the over-
lap in expression of the binding target proteins with Scarf in the
cytoplasm and nuclei of the epidermal, differentiated layers.
Changes in Expression Level and Localization after Alteration
of Intracellular Ca2Concentration—Acute disruptions of epi-
dermal permeability barrier function by either repeated tape
stripping or acetone treatment tran-
siently change the epidermal Ca2
gradient, inducing a decrease in
Ca2 levels in the outer epidermis
(12). To understand the possible
function of Scarf and its binding tar-
get proteins in the maintenance of
the epidermal Ca2 gradient, we
disrupted the epidermal barrier by
tape stripping and collected skin
samples at 3, 6, and 24 h after the
disruption. The change in the
expression level of Scarf and its
binding target proteins was ana-
lyzed by immunohistochemistry
andWestern blot studies using skin
sections and cell extracts of samples
untreated (control) and after barrier
disruption.
As shown in Fig. 5A, the expres-
sion level of Scarf increased in the
granular layers and in the nuclei of
cells in the spinous layer 24 h after
acute barrier disruption. This
change in expression levels is
already detected in skin samples
obtained 3 and 6 h after barrier
disruption (data not shown), with
the highest level of change visual-
ized at 24 h after disruption (Fig.
5A). This result suggests that the
increase in Scarf expression may
precede the recovery of the epi-
dermal Ca2 gradient following
the disruption. In addition, the
expression level of annexin II,
annexin V, calreticulin, and ERp72
are also increased 24 h after the
disruption, whereas the expres-
sion levels of 14-3-3, 14-3-3,
and nucleolin decrease (Fig. 5).
Filaggrin was used as a control,
and its expression decreased in
these experiments. This is consist-
ent with previous reports that show filaggrin mRNA level
decreases after acute barrier disruption and is restored after
6–24 h (12).
Distinct changes in the localization of Scarf and some of its
binding target proteins were also evaluated. Fig. 6A shows that
Scarf and annexin V are both up-regulated and become co-
localized at nuclear envelopes and nuclei in the suprabasal lay-
ers of the mouse epidermis after acute barrier disruption.
Translocation was also observed in transfected mouse kerati-
nocytes. Cells co-transfected with Scarf and annexin V were
treated with ionomycin to increase the intracellular Ca2 con-
centration. In this setting, both Scarf and annexin V translocate
to the nucleus after treatment with ionomycin (Fig. 6B). The
results from these two different approaches indicate that the
Control 24 h 
Scarf
H & E
staining
ANX II
A
B
ANX V
14-3-3 σ
14-3-3 β
Control 24 h 
CRT
ERp72
NUC
FIL
Scarf
C 24h
14-3-3 β
14-3-3 σ
ANX II
C 24h
ANX V
CRT
ERp72
NUC
FIL
FIGURE5.Changes inexpressionpatternsand levelsofScarf and itsbinding targetproteinsduringacute
epidermal barrier disruption. Acute barrier disruption was performed by repeated tape stripping, and
mouse skin samples were collected 24 h after treatment. Changes in expression patterns and levels of Scarf,
annexin II, annexin V, calreticulin, ERp72, 14-3-3, 14-3-3, and nucleolin after acute barrier disruption were
detected by immunohistochemistry (A) andWestern blot analysis (B). A dotted line demarcates the epidermis/
dermis junction. Scale bar, 30 m.
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expression of Scarf and some of its binding target proteins is
up-regulated and the proteins can be relocated by changes in
intracellular Ca2 concentration.
Role of Scarf in Human Skin during Wound Healing—Corre-
lation between skin injury and Ca2-binding protein function
has been reported on studies with S100 proteins, which show
that S100A8 and its dimerization partner, S100A9, are strongly
up-regulated duringwoundhealing, whereas their expression is
very low in normal epidermis (28). We next investigated
whether the Scarf human homolog, Clsp, was also up-regulated
during wound repair in skin. Normal human skin was wounded
by 3-mm biopsy punch and maintained at the air-liquid inter-
face for 4, 7, and 12 days.We performed immunohistochemical
analysis of the epidermis at the edge of the wounds utilizing the
chicken anti-Scarf antibody that detects the human homolog
Clsp (human calmodulin-like skin protein) but shows no cross-
reactivity with related Ca2-binding proteins such as calmod-
ulin or human calmodulin-like protein (22). As expected, we
found Clsp/Scarf expression in the granular, differentiated lay-
ers of the unwounded human skin (18), similar to mouse epi-
dermis (Fig. 7). Interestingly, 4 days, and even more promi-
nently, 7 days after wounding, Clsp/Scarf expression was
increased and expanded through
granular and spinous layers of the
epidermis (Fig. 7), similar to the epi-
dermis after tape stripping. In addi-
tion, we found that Clsp/Scarf local-
izes to nuclei of the keratinocytes at
4 and 7 days post-wounding,
whereas both expression and
nuclear presence are restored to the
base levels at 12 days post-wound-
ing when the repair process is com-
pleted (data not shown). Taken
together, we propose that Clsp/
Scarf potentially participates in late
stages of the wound healing process
in epidermis, suggesting a role in
epidermal barrier restoration.
DISCUSSION
In eukaryotic systems, Ca2 ions
are crucial in a variety of cellular sig-
naling pathways. Epidermal differ-
entiation is a Ca2-dependent proc-
ess that is accompanied by increases
in intracellular Ca2 concentration
from the proliferative basal com-
partment to the terminally differen-
tiated, cornified layer of the skin
(12). Ca2-dependent signaling sys-
tems respond to transient variations
in Ca2 concentration through
members of the family of highly
homologous Ca2-binding factors.
These proteins function by under-
going conformational changes upon
binding Ca2, which enable them to
interact with specific targets and in this way modulate their
function. We previously reported a novel protein Scarf charac-
terized by the presence of four Ca2-binding EF-hand motifs,
which are highly expressed in the differentiated layers of the
mouse stratified epidermis (22, 23). The cell specificity of Scarf
expression suggests a role in the regulation of effector proteins
in Ca2 signaling-dependent pathways in keratinocytes. The
primary goals of this study were to determine the binding tar-
gets and putative functions of Scarf in Ca2 homeostasis and
epidermal differentiation.
Seven binding target proteins were identified by affinity
chromatography and mass spectrometry (14-3-3, 14-3-3,
annexin II, annexin V, calreticulin, ERp72, and nucleolin), and
their interactions with Scarf were verified by co-immunopre-
cipitation and co-localization studies. Recent reports have
summarized the crucial roles of these proteins in diverse pro-
cesses. 14-3-3s proteins are a family of seven (/, , , , /	,

/, and) highly conserved phosphoserine/threonine-binding
factors that participate in a wide range of signaling pathways,
i.e. signal transduction, cell cycle regulation and differentiation,
apoptosis, and stress responses (29–31). Annexins are phos-
pholipid-binding proteins that associate with membrane lipids
A
B
FIGURE 6.Calcium-dependent localization of Scarf and annexin V in both barrier-disrupted skin andmouse
keratinocytes.TranslocationofScarfandannexinVwasdetected inafteracutebarrierdisruption (A) andtreatment
with ionomycin tomouse keratinocytes (B). Scarf was stained using a secondary FITC-conjugated antibody (green),
and annexin V was visualized by rhodamine-conjugated secondary antibody (red). A dotted line demarcates the
epidermis/dermis junction. Scale bar, 30m inA and 10m in B.
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in a Ca2-dependentmanner and function in cellular ormolec-
ular trafficking (32). Calreticulin bindsCa2 in the lumen of the
ER andplays critical roles in the regulation ofCa2homeostasis
(33, 34). ERp72 is one of the protein disulfide isomerases pres-
ent in the ER that participates as a molecular chaperone and in
protein folding (35). Nucleolin is a nuclear phosphoprotein
associated with preribosomal RNA that has been implicated in
the regulation of rDNA transcription and nucleocytoplasmic
transport (36). The overall commonality between the Scarf-
binding target proteins is that they are implicated in the regu-
lation of cellular Ca2 homeostasis at different levels and in
intracellular localization, (Fig. 8) and our results demonstrate
that the interaction with Scarf is Ca2-dependent (Fig. 3).
Some of the binding target proteins identified for Scarf in this
study, i.e. annexins and nucleolin, have also been shown to
interact with S100 familymembers. The S100multigenic family
comprises 21 Ca2-modulated proteins of the EF-hand type
with intracellular and extracellular regulatory activities (19, 21).
Fourteen members of this family of genes are encoded in the
epidermal differentiation complex located on human chromo-
some 1q21, most of which are expressed in normal and/or dis-
eased epidermis (20). Similar to what has been demonstrated
for calmodulin, S100 proteins can bind to binding target pro-
teins after undergoing conformational changes upon binding
Ca2. Interactions of S100 proteins and annexins have been
reported, S100A6 with annexin XI, S100A10 with annexin II,
and S100A11 with annexin I (37). Furthermore, calcium-de-
pendent co-localization at the nuclear envelope of cells was
reported in the case of S100A6 and annexin XI (38). Structural
and functional studies have shown that annexin II exists in cells
as either a monomer or a heterotetramer complexed with
S100A10 Ca2-binding protein, which participates in the
Ca2-induced exocytosis of secretory granules and localizes to
endosomes in the endocytic pathway (32). The formation of
junctions between the lipid membrane and [S100A10-annexin
II]2 heterotetramer has been studied by both electron micros-
copy and atomic force microscopy (39, 40). Recent reports
show that S100A11-annexin I also forms heterotetramers (41)
that may be involved in remodeling plasma membrane struc-
tures, functions as an activated channel that mediates Ca2
influx, and/or serves as a structural component of the cornified
envelope (20). These activities would require a relocation of
S100A11 to the cell periphery, which has been demonstrated to
be dependent on Ca2 and the presence of intact microtubules
(42, 43). Furthermore, S100A11 has also been proposed to be a
mediator of Ca2-induced growth arrest in keratinocytes
through a mechanism that involves the interaction with
nucleolin (44, 45). Although the specific physiological function
of S100 proteins is still being studied, there is increasing evi-
dence of their role in activities related to inflammatory pro-
cesses, with several of the family members being highly up-reg-
ulated in epidermal inflammatory diseases such as psoriasis and
atopic dermatitis (19, 20). It will be of great interest to evaluate
whether there are similar pathways and functional roles for
Scarf in these pathological conditions.
Another family of factors that has drawnmuch interest is the
14-3-3 proteins, which can bind in a phosphorylation-depend-
ent fashion to important cytoplasmic and nuclear proteins and
in this way prevent/promote the interactions with other pro-
teins, modulate the activity of enzymes, sequester proteins in
particular subcellular compartments, or work as adaptors to
bridge two proteins (31, 46). 14-3-3s form homodimers or het-
erodimers that bind to the consensus motifs RSXpSXP and
C
4 d 
7 d 
FIGURE 7. Expression of Clsp (Scarf human homolog) in human skin dur-
ingwoundhealing. The expressionof theCa2-bindingprotein inhuman skin
wasdetectedusinganti-Scarf antibody (green). Theexpression level increasedby
7 days after skinwounding. The right panels are themagnifications of the circled
areas in the left panels. The nuclei were visualized using Hoechst staining (blue).
Left panel scale bar, 30m.Right panel scale bar, 10m.
FIGURE 8. Schematic diagramof the Scarf-mediated Ca2homeostasis in
keratinocytes. The Ca2-dependent interactions of Scarf with annexins, cal-
reticulin, and ERp72 may play crucial roles in Ca2 homeostasis, molecular
trafficking, and chaperone activity, and interactions with 14-3-3, 14-3-3,
and nucleolin are potentially involved in growth inhibition and differentia-
tion of keratinocytes.
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RX(Y/F)XpSXP (X is any amino acid and pS is phosphoserine or
phosphothreonine) present in almost all of their binding targets
(31, 46). Some of themany targets reported for 14-3-3 isoforms,
i.e. nucleolin, annexins, and 14-3-3 themselves (47, 48) were
also shown to interact with Scarf. 14-3-3s have previously been
implicated in human wound healing, being involved in the reg-
ulation of keratinocytemigration to the closure site (49, 50) and
in the modulation of keratin filaments and mitotic progression
(51). To further substantiate the important role of this family in
keratinocyte biology, a recent report demonstrates that keratin
17 regulates cell growth by interaction with 14-3-3s (52). Scarf
does not contain the sequence motifs for binding 14-3-3 pro-
teins in a phosphoserine-dependentmanner.However, alterna-
tive mechanisms have been recently reported for 14-3-3 inter-
actions with 1 integrin (53). It is possible that the interaction
between Scarf and 14-3-3 proteins is also achieved through a
distinct motif. Alternatively, the interaction could be indirect,
forming a complex with a not-yet-identified bridging protein.
Due to the established central role of Ca2 in skin barrier
acquisition and maintenance and to better understand the
effects of change in Ca2 concentration in skin on Scarf and its
binding proteins, we analyzed Scarf expression after acute epi-
dermal water barrier disruption and in wound healing. We
found that Scarf expression increases after barrier disruption,
indicating a potential role for Scarf in maintaining Ca2 home-
ostasis by sensing and regulating the increase of intracellular
Ca2 concentration by both influx across the plasma mem-
brane and release from the ER. Moreover, the expression level
of annexin II, annexin V, calreticulin, and ERp72, which are
involved in Ca2-induced exo- and endocytosis, regulation of
Ca2 homeostasis and protein synthesis, increases at 6 h after
barrier disruption, whereas the expression of 14-3-3, 14-3-3,
and nucleolin, implicated in Ca2-induced growth inhibition
and differentiation of keratinocytes, decreases. These results
are in agreement with the report by Elias et al. (12) that shows
decreased expression of differentiation-specific proteins while
the secretion of lamellar bodies occurs simultaneously as a
result of the disruption. An additional aspect studied was the
calcium-dependent nuclear localization of Scarf and annexinV.
Scarf and annexin V co-localized in the nucleus after increased
intracellular Ca2 concentration due to ionomycin treatment,
re-emphasizing the crucial role of Ca2 in the control of sub-
cellular localization and the potential function of these factors.
The physiological importance of this nuclear localization
remains to be elucidated; however, the potential relevance is
substantiated by similar nuclear translocations of annexin V,
annexin XI, and 14-3-3 being found to be calcium and/or cell
cycle-dependent (30, 32, 38, 52).
The second in vivo system utilized to study Scarf function
was during wound healing. The ultimate goal of the wound
healing process in epidermis is barrier restoration (54). In our
human experimental model, complete closure is achieved
between days 9 and 10.We found that, at day 4 of post-wound-
ing, Clsp/Scarf is being induced, expanding through granular
and spinous layers, having the highest increase at day 7. Its
nuclear localization in keratinocytes at the edge of the wound
indicates a plausible active role during this process. This spa-
tiotemporal increase in Clsp/Scarf protein and its activity dur-
ing wound healing in epidermis is biologically very relevant.
During the early phases of wound healing, keratinocytes first
migrate and subsequently proliferate to fill the gap (54). Clsp/
Scarf expression was not increased during these early stages.
However, we have shown that expression substantially
increased at the timewhen keratinocytes were shifting from the
activated to the differentiating state to restore the barrier. This
would suggest that Clsp/Scarf plays an important role in late
epidermal wound healing, perhaps participating in the change
from activated to differentiating keratinocyte phenotype.
It is of immediate interest to determine how these variations
in expression and/or altered interaction between Scarf and its
binding target proteins translate to the maintenance of the
Ca2 gradient, differentiation, barrier maintenance, and
wound healing and how Scarf function relates these processes
to one another and the overall Ca2 homeostasis of the skin.
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